Omeprazole
💊 Brand Formulations & Prices
249 brands sorted by unit price
Omep
Lomesec
Losectil
Xeldrin
OM
G-Omeprazole
Gastridine
Omag-DR
Omet
Aumi
Besectil
Gem
Healer
Inhibita
Losek
Mepra
Neome
OC-20
Omectil
Ometop
Opezen
Osyn-20
Presectil
Protobit
Ranzo
Romilok
Seclotil
Som
Omepra
Prazover DR
AU-20
Omitin
Opra
Ozole
Pear
Rampro
Omehil
Aspra
Deu
Emez
Eupi
Gastril
HK
Inpro
Loprazol
Losectil
Losectil V
Neopra
Nuprazol
O-20
OP-20
Olzep
Omaprin
Omeben
Omecap
Omecron
Omegut
Omel
Omemed
Omenix
Omeprol
Ometac
Omevir
Omezole
Omidex
Omiloc
Omilux
Omitac
Omixen
Ompa
Omsec
Opal
Orpra
Peplo
Perizol
Piazol
Prazole
Prazomax
Presec
Prevas
Prevastin
Proceptin
Promezol
Re 20
Regerd
Roceptin
Rome
SB-Omec
Savzol
Seclogen
Secton
Seloktil
Zolat
PPI
Prazover
Propin
Anasec
Omegel
Omelet
Omex
Omilant
Prevencid
Xelopes
Xerosec
Zilon
Cosec
OME
Omenaaf
Omesic
Omirex
Omrazol
Prazo
Prolok
Re 40
Omesil
Gap
Gastrocare
Lovanzo
Minisec
OM
OPmax
Omecent
Omenta
Omep
Ometem
Ometid
Ometor
Omimak
Omizit
Onelock
Peptral
Procap
Seclo
Seclotil
Sectil
Stosec
Tase
Xeldrin
Cosec-MUPS
Inhibita
Losectil MUPS
Losek
O-40
Omeben MUPS
Omeprol
Ometid MUPS
Omitin
Omsec
Opezen
Prazomax
Presec
Seclo MUPS
Sectil
Zolat
Omelet
Omepra
Omex
Xelopes
Omegut
Ometid
Probitor
Aumi
Zilon
Propin
Aspra
Emez
Inpro
Losectil V
OME
OP-40
OPmax
Omeben
Omecent
Omehil
Omel
Omemed
Omenix
Omep
Ometem
Omrazol
Opal
Peplo
Perizol
Prevas
Proceptin
Regerd
Roceptin
SB-Omec
Savzol
Tase
Omecron
Omirex
Procap
Xerosec
Omecare
Prazover
Prevencid
Promezol
Cosec
Omesic
Gap
Losectil
Minisec
Onelock
PPI
Prolok
Seclo
Seclogen
Xeldrin
Peptral
Cosec-MUPS
Losectil MUPS
Ometid MUPS
Probitor
Omsec
Gastril
Inpro
Anasec
G-Omeprazole
Deu
OP-40
Omecron
Omegut
Omep
Ometor
Prevas
Gap
Losectil
Omecap
Omenix
Omenta
Omeprol
Omex
PPI
Prolok
Stosec
Xeldrin
Ometid
Procap
Xelopes
Cosec
Opal
Seclo
Proceptin
Omenix
Omesil Fast
Losectil
Omenix
Losectil
📖 Official Clinical Monograph
DGDA Approved Prescribing GuidelinesAnasec is indicated for the treatment of-
Gastric and duodenal ulcer
NSAID-associated duodenal and gastric ulcer
As prophylaxis in patients with a history of NSAID-associated duodenal and gastric ulcer
Gastro-esophageal reflux disease
Long-term management of acid reflux disease
Acid-related dyspepsia
Severe ulcerating reflux esophagitis
Prophylaxis of acid aspiration during general anesthesia
Zollinger-Ellison syndrome
Helicobacter pylori-induced peptic ulcer.
Omeprazole is contraindicated in patients with known hypersensitivity to it. When gastric ulcer is suspected, the possibility of malignancy should be excluded before treatment with omeprazole is instituted, as treatment may alleviate symptoms and delay diagnosis.
Anasec is well tolerated and adverse reactions have generally been mild and reversible. Skin rash, urticaria and pruritus have been reported. Usually resolving after discontinuation of treatment. In addition photosensitivity, bullous eruption, erythema multiforme, angioedema and alopecia have been reported in isolated cases. Diarrhoea and headache have been reported and may be severe enough to require discontinuation of therapy in a small number of patients. In the majority of cases the symptoms resolved after discontinuation of therapy. Other gastrointestinal reactions have included constipation, nausea/vomiting, flatulence and abdominal pain. Dry mouth, stomatitis and candidiasis have been reported as isolated cases. Paraesthesia has been reported. Dizziness, light headedness and feeling faint have been associated with treatment, but all usually resolve on cessation of therapy. Also reported are somnolence, insomnia and vertigo. Reversible mental confusion, agitation, depression and hallucinations have occurred predominantly in severely ill patients. Arthritic and myalgic symptoms have been reported and have usually resolved when therapy is stopped. In isolated cases, the following have been reported: blurred vision, taste disturbance, peripheral oedema, increased sweating, gynaecomastia, leucopenia, thrombocytopenia, agranulocytosis, pancytopenia, anaphylactic shock, malaise, fever, bronchospasm, encephalopathy in patients with pre-existing severe liver disease, hepatitis with or without jaundice, rarely interstitial nephritis and hepatic failure. Increases in liver enzymes have been observed.
Avoid concomitant use of clopidogrel and Anasec as the pharmacological activity of clopidogrel is reduced if given concomitantly. Observational studies suggest that proton pump inhibitor (PPI) therapy may be associated with an increased risk for osteoporosis- related fractures of the hip, wrist, or spine. Atrophic gastritis has been noted occasionally in gastric corpus biopsies from patients treated long-term with Anasec. Concomitant use of PPIs with methotrexate may lead to methotrexate toxicities.
Omeprazole, a substituted benzimidazole, is an inhibitor of gastric acid secretion. It inhibits gastric acid secretion by blocking hydrogen-potassium-adenosine triphosphatase (H
+
/K
+
ATPase) enzyme system in the gastric parietal cell. After oral administration, the onset of the antisecretory effect occurs within one hour, with the maximum effect occurring within two hours and inhibition of secretion lasts up to 72 hours. When the drug is discontinued, secretory activity returns gradually, over 3 to 5 days.